Healthcare & Life Sciences

Latham offers life sciences and healthcare industry leaders deep sector knowledge, legal expertise, and commercial and government insight to meet client needs.

Why Latham

Melding Deep Industry Experience with Commercial Insight

Companies operating in the healthcare and life sciences sectors face an increasingly complex transactional, political, and competitive landscape. Latham’s superior grasp of the regulatory regimes and market issues means that clients can adroitly and expeditiously address litigation, mergers and acquisitions, capital raising, regulatory counseling, business restructuring and reorganization, contract negotiations, fraud and abuse compliance, white collar and government investigations, operational matters, and more.

Learn more about Latham’s Healthcare & Life Sciences industry experience.

Awards & Rankings

  • Healthcare & Life Sciences Counsel Named Among Top Healthcare Lawyers in California - November 07, 2021
  • Intellectual Property Litigation Practice Honored at National Law Journal’s Professional Excellence Awards - October 24, 2021
  • Latham Honored at National Law Journal’s Professional Excellence Awards - October 24, 2021
  • Latham Named 2021 Massachusetts Regional Powerhouse - August 08, 2021
  • 10 Latham Lawyers Named 2021 Rising Stars - May 31, 2021

Latham has a "strong bench of former government attorneys who field expertise across numerous US departments and offices" and a "dominant presence in qui tam suits and criminal proceedings, as well as frequent involvement in complex transactions, including high-value M&A.”

– Chambers USA 2020

Events

Webcast – FDA Regulatory Updates and 2020 Outlook for Vaping and Cannabis-Derived Substances

Media Coverage

United Therapeutics Beats HHS’ Discount-Dodging ClaimsLitigator of the Week Runners-Up and Shout OutsFederal Circuit Axes Philips Heart Monitor Patent Under Alice

News

Latham & Watkins Advises P3 Health Partners in Completed Business Combination with Foresight Acquisition Corp.Latham & Watkins Advises Sirona Medical on US$40 Million Series B FundingLatham & Watkins Advises Africa Health Holdings on US$18 Million Series A Funding

Thought Leadership

Healthcare & Life Sciences: Drug Pricing DigestMHRA Seeks New Regulatory Regime for Medical Devices, DiagnosticsHealthcare & Life Sciences: Drug Pricing Digest

Webcasts & Podcasts

Telehealth Innovations: Legal Considerations for Digital Health Companies Engaging in Value-Based CareThe Biden Administration’s Regulatory and Enforcement Priorities: A Six-Month UpdateDrug and Device Pricing and Reimbursement Landscape: Legal and Policy Trends Under the Biden Administration